The feds have signed deals with pharmaceutical companies Novavax and Johnson & Johnson to reserve tens of millions of doses of a potential COVID-19 vaccine, provided that it’s safe and effective. Mike Le Couteur reports on the politics at play in securing a vaccine.
- Novavax begins late-stage trial of coronavirus vaccine in U.S.
- Canada finalizes Novavax deal to buy up to 72 million more COVID-19 vaccine doses